Literature DB >> 24835359

Ulinastatin activates haem oxygenase 1 antioxidant pathway and attenuates allergic inflammation.

Dongmei Song1, Geng Song, Yinghao Niu, Wei Song, Jiantao Wang, Lei Yu, Jianwang Yang, Xin Lv, Harry Steinberg, Shu Fang Liu, Baoshan Wang.   

Abstract

BACKGROUND AND
PURPOSE: Ulinastatin (UTI), a serine protease inhibitor, was recently found to have an anti-inflammatory action. However, the mechanisms mediating this anti-inflammatory effect are not well understood. This study tested the hypothesis that UTI suppresses allergic inflammation by inducing the expression of haem oxygenase 1 (HO1). EXPERIMENTAL APPROACH: Control mice and mice sensitized (on days 1, 9 and 14) and challenged (on days 21 to 27) with ovalbumin (OVA) were treated with UTI. The effects of UTI on basal expression of HO1 and that induced by OVA challenge were examined. The involvement of UTI-induced HO1 expression in anti-inflammatory and antioxidant effects of UTI was also evaluated. KEY
RESULTS: UTI markedly increased basal HO1 protein expression in lungs of control mice in a time- and dose-dependent manner, and augmented HO1 protein expression induced by OVA. The up-regulation of HO1 mediated by UTI in sensitized and OVA-challenged mice was associated with reduced airway inflammation, alleviated tissue injury, reduced oxidant stress and enhanced antioxidant enzyme activities. Inhibition of HO1 activity using HO1 inhibitor, zinc protoporphyrin, attenuated inhibitory effects of UTI on inflammation and oxidant stress, and its stimulant effects on antioxidant enzyme activities. Mechanistic analysis showed that UTI increased nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf2), stimulated Nrf2 DNA binding activity and concomitantly up-regulated HO1 mRNA expression. CONCLUSIONS AND IMPLICATIONS: UTI is a potent and naturally occurring inducer of HO1 expression. HO1 up-regulation contributes significantly to the anti-inflammatory and organ-protective effects of UTI, which has important research and therapeutic implications.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24835359      PMCID: PMC4209147          DOI: 10.1111/bph.12780

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines.

Authors:  J C McGrath; G B Drummond; E M McLachlan; C Kilkenny; C L Wainwright
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis.

Authors:  Shehzad Z Sheikh; Refaat A Hegazi; Taku Kobayashi; Joseph C Onyiah; Steven M Russo; Katsuyoshi Matsuoka; Antonia R Sepulveda; Fengling Li; Leo E Otterbein; Scott E Plevy
Journal:  J Immunol       Date:  2011-03-28       Impact factor: 5.422

4.  Urinary trypsin inhibitor suppresses excessive generation of superoxide anion radical, systemic inflammation, oxidative stress, and endothelial injury in endotoxemic rats.

Authors:  Ryo Tanaka; Motoki Fujita; Ryosuke Tsuruta; Kenji Fujimoto; Hiromi Shinagawa Aki; Kazumi Kumagai; Tetsuya Aoki; Akihiro Kobayashi; Tomonori Izumi; Shunji Kasaoka; Makoto Yuasa; Tsuyoshi Maekawa
Journal:  Inflamm Res       Date:  2010-02-11       Impact factor: 4.575

Review 5.  Pathogenesis of allergic airway inflammation.

Authors:  Devendra K Agrawal; Zhifei Shao
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

6.  Urinary trypsin inhibitor suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats.

Authors:  Yasutaka Koga; Motoki Fujita; Ryosuke Tsuruta; Yoichi Koda; Takashi Nakahara; Takeshi Yagi; Tetsuya Aoki; Chihiro Kobayashi; Tomonori Izumi; Shunji Kasaoka; Makoto Yuasa; Tsuyoshi Maekawa
Journal:  Neurol Res       Date:  2010-03-10       Impact factor: 2.448

Review 7.  Heme oxygenase-1 in lung disease.

Authors:  Chintan M Raval; Patty J Lee
Journal:  Curr Drug Targets       Date:  2010-12       Impact factor: 3.465

Review 8.  Mechanisms of cell protection by heme oxygenase-1.

Authors:  Raffaella Gozzelino; Viktoria Jeney; Miguel P Soares
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

9.  Treatment of patients with severe sepsis using ulinastatin and thymosin alpha1: a prospective, randomized, controlled pilot study.

Authors:  Hao Chen; Ming-yan He; Yu-min Li
Journal:  Chin Med J (Engl)       Date:  2009-04-20       Impact factor: 2.628

10.  [Effect of budesonide on the heme oxygenase-1 expression in lung tissues of rats with asthma].

Authors:  Xuan Xu; Li-Li Zhong; Su-Min Jiao; San-San Liu; Yun Li; Bing Zhang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2008-06
View more
  8 in total

1.  Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway.

Authors:  Si-Tong Li; Qi Dai; Shu-Xian Zhang; Ya-Jun Liu; Qiu-Qiong Yu; Fei Tan; Shu-Hong Lu; Quan Wang; Jian-Wen Chen; He-Qing Huang; Pei-Qing Liu; Min Li
Journal:  Acta Pharmacol Sin       Date:  2018-01-11       Impact factor: 6.150

2.  Ulinastatin Alleviates Rhabdomyolysis-Induced Acute Kidney Injury by Suppressing Inflammation and Apoptosis via Inhibiting TLR4/NF-κB Signaling Pathway.

Authors:  Jinxiang Wang; Guowu Xu; Heng Jin; Yanfen Chai; Xinyue Yang; Ziquan Liu; Shike Hou; Haojun Fan
Journal:  Inflammation       Date:  2022-06-06       Impact factor: 4.657

3.  Anti-Inflammatory Effect of Ulinastatin on the Association Between Inflammatory Phenotypes in Acute Type A Aortic Dissection.

Authors:  Hong Liu; Si-Chong Qian; Yong-Feng Shao; Hai-Yang Li
Journal:  J Inflamm Res       Date:  2022-06-27

4.  Ulinastatin alleviates cerebral ischemia-reperfusion injury in rats by activating the Nrf-2/HO-1 signaling pathway.

Authors:  Lei Cui; Wei Cao; Yanmin Xia; Xiaofang Li
Journal:  Ann Transl Med       Date:  2020-09

5.  Ulinastatin Protects against CVB3-Induced Acute Viral Myocarditis through Nrf2 Activation.

Authors:  Fangqiang Song; Fanpo Kong; Hongqing Zhang; Yongqin Zhou; Ming Li
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

6.  Hydrogen Attenuates Allergic Inflammation by Reversing Energy Metabolic Pathway Switch.

Authors:  Yinghao Niu; Qingrong Nie; Liping Dong; Jihua Zhang; Shu Fang Liu; Wei Song; Xiaopei Wang; Guangli Wu; Dongmei Song
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

7.  Ulinastatin inhibits NLRP3-induced apoptosis in a PD cell model.

Authors:  Yicheng Lin; Dongsheng Xu; Feng Gao; Xiaolei Zheng
Journal:  Ann Transl Med       Date:  2021-06

8.  Ulinastatin alleviates early brain injury after intracerebral hemorrhage by inhibiting oxidative stress and neuroinflammation via ROS/MAPK/Nrf2 signaling pathway.

Authors:  Xi Wu; Wei Jiao; Junhui Chen; Yunna Tao; Jing Zhang; Yuhai Wang
Journal:  Acta Cir Bras       Date:  2022-09-05       Impact factor: 1.564

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.